FCH
GILD icon

Freestone Capital Holdings’s Gilead Sciences GILD Stock Holding History

Freestone Capital Holdings’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.12M Buy
8,873
+223
+3% +$29.4K 0.03% 243
2026
Q1 		$1.21M Buy
8,650
+17
+0.2% +$2.38K 0.04% 220
2025
Q4 		$1.06M Sell
8,633
-114
-1% -$13.9K 0.03% 237
2025
Q3 		$971K Buy
8,747
+2,983
+52% +$339K 0.03% 254
2025
Q2 		$639K Sell
5,764
-1,159
-17% -$123K 0.02% 262
2025
Q1 		$776K Sell
6,923
-595
-8% -$61.4K 0.03% 236
2024
Q4 		$694K Sell
7,518
-1,476
-16% -$133K 0.02% 251
2024
Q3 		$754K Sell
8,994
-866
-9% -$66.1K 0.03% 249
2024
Q2 		$676K Sell
9,860
-717
-7% -$47.8K 0.02% 258
2024
Q1 		$775K Sell
10,577
-437
-4% -$33.6K 0.03% 243
2023
Q4 		$892K Sell
11,014
-272
-2% -$21.2K 0.04% 217
2023
Q3 		$846K Sell
11,286
-5,018
-31% -$386K 0.04% 193
2023
Q2 		$1.26M Sell
16,304
-2,067
-11% -$165K 0.05% 173
2023
Q1 		$1.52M Sell
18,371
-443
-2% -$36.7K 0.07% 161
2022
Q4 		$1.62M Sell
18,814
-15,017
-44% -$1.19M 0.07% 153
2022
Q3 		$2.09M Sell
33,831
-14,544
-30% -$917K 0.09% 138
2022
Q2 		$2.99M Sell
48,375
-6,618
-12% -$410K 0.11% 126
2022
Q1 		$3.27M Sell
54,993
-965
-2% -$61.7K 0.13% 150
2021
Q4 		$4.06M Sell
55,958
-1,410
-2% -$97.1K 0.17% 124
2021
Q3 		$4.01M Buy
57,368
+414
+0.7% +$29.1K 0.2% 116
2021
Q2 		$3.92M Sell
56,954
-240
-0.4% -$16K 0.2% 124
2021
Q1 		$3.7M Buy
57,194
+2,326
+4% +$150K 0.2% 122
2020
Q4 		$3.2M Buy
54,868
+9,592
+21% +$579K 0.19% 130
2020
Q3 		$2.86M Buy
45,276
+937
+2% +$65K 0.19% 115
2020
Q2 		$3.41K Sell
44,339
-392
-0.9% -$30K 0.04% 110
2020
Q1 		$3.34K Sell
44,731
-18,960
-30% -$1.31M 0.07% 98
2019
Q4 		$4.14K Sell
63,691
-9,597
-13% -$625K 0.09% 98
2019
Q3 		$4.64K Sell
73,288
-14,838
-17% -$970K 0.11% 83
2019
Q2 		$5.95K Sell
88,126
-149,581
-63% -$9.84M 0.15% 78
2019
Q1 		$15.5M Buy
237,707
+39,185
+20% +$2.6M 0.92% 23
2018
Q4 		$12.4M Sell
198,522
-123,325
-38% -$8.62M 0.84% 30
2018
Q3 		$24.9M Buy
321,847
+6,225
+2% +$470K 0.16% 16
2018
Q2 		$22.4M Buy
315,622
+4,878
+2% +$344K 0.14% 19
2018
Q1 		$23.4M Buy
310,744
+21,111
+7% +$1.68M 1.37% 15
2017
Q4 		$20.8M Buy
289,633
+2,648
+0.9% +$201K 1.44% 14
2017
Q3 		$23.3M Buy
286,985
+4,442
+2% +$340K 1.65% 8
2017
Q2 		$20M Buy
282,543
+6,027
+2% +$401K 1.56% 17
2017
Q1 		$18.8M Buy
276,516
+85,805
+45% +$6.03M 1.45% 25
2016
Q4 		$13.7M Buy
190,711
+7,134
+4% +$530K 1.17% 26
2016
Q3 		$14.5M Sell
183,577
-10,391
-5% -$844K 1.33% 26
2016
Q2 		$16.2M Buy
193,968
+13,681
+8% +$1.21M 1.58% 25
2016
Q1 		$16.6M Buy
180,287
+2,637
+1% +$238K 1.74% 23
2015
Q4 		$18M Buy
177,650
+5,448
+3% +$567K 1.86% 16
2015
Q3 		$16.9M Buy
172,202
+4,186
+2% +$465K 1.84% 15
2015
Q2 		$19.7M Buy
168,016
+5,116
+3% +$559K 3.13% 2
2015
Q1 		$16M Buy
162,900
+157,540
+2,939% +$16M 2.52% 22
2014
Q4 		$505K Buy
+5,360
New +$554K 0.08% 134
2014
Q1 		– Sell
-9,036
Closed -$679K – 257
2013
Q4 		$679K Sell
9,036
-7,267
-45% -$506K 0.12% 146
2013
Q3 		$1.03M Buy
16,303
+567
+4% +$33.9K 0.18% 109
2013
Q2 		$807K Buy
+15,736
New +$820K 0.17% 108

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Nordea Investment Management
Nordea Investment Management Stockholm, Sweden $123B AUM 38.85% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Mitsubishi UFJ Asset Management
Mitsubishi UFJ Asset Management Tokyo, Japan $180B AUM 37.51% 1-Year Est. Return

Freestone Capital Holdings's GILD Position: Q2 2026 in Review

Freestone Capital Holdings increased its Gilead Sciences (GILD) stake by 2.6% in Q2 2026, buying an estimated $29.4K and bringing the position to 8,873 shares worth $1.12M. The position accounts for 0.03% of the portfolio, ranked #243.

Freestone Capital Holdings first reported a position in GILD in Q2 2013 and has held it in 50 quarters since. The position peaked at $24.9M in Q3 2018. 1,412 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Freestone Capital Holdings held 8,873 shares of Gilead Sciences worth $1.12M as of Q2 2026.
  • Freestone Capital Holdings bought 223 Gilead Sciences shares in Q2 2026, an estimated $29.4K.
  • Gilead Sciences made up 0.03% of Freestone Capital Holdings's portfolio in Q2 2026, its #243 holding.
  • Freestone Capital Holdings first reported a position in Gilead Sciences in Q2 2013 and has held it in 50 quarters since.
  • Freestone Capital Holdings's Gilead Sciences position peaked at $24.9M in Q3 2018.
  • 1,412 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Freestone Capital Holdings's 13F filing for Q2 2026, filed 31 Jul 2026.